Desmopressin: Difference between revisions
(Created page with "==Administration== *Type: *Dosage Forms: *Routes of Administration: *Common Trade Names: DDAVP ==Adult Dosing== ==Pediatric Dosing== ==Special Populations== *Drug Rating...") |
(desmopressin edits) |
||
| Line 1: | Line 1: | ||
==Administration== | ==Administration== | ||
*Type: | *Type: synthetic replacement for vasopressin | ||
*Dosage Forms: | *Dosage Forms: | ||
*Routes of Administration: | **injectable solution: 4 mcg/mL | ||
*Common Trade Names: DDAVP | **tablet: 0.1 mg, 0.2 mg | ||
**nasal spray: 0.1 mg/ mL (5mL); Delivers 10 mcg/spray, 1.5 mg/mL (2.5mL); Delivers 150 mcg/spray | |||
*Routes of Administration: IV, IM, SC, intranasal, oral | |||
*Common Trade Names: DDAVP, Stimate | |||
==Adult Dosing== | ==Adult Dosing== | ||
Revision as of 02:57, 7 February 2016
Administration
- Type: synthetic replacement for vasopressin
- Dosage Forms:
- injectable solution: 4 mcg/mL
- tablet: 0.1 mg, 0.2 mg
- nasal spray: 0.1 mg/ mL (5mL); Delivers 10 mcg/spray, 1.5 mg/mL (2.5mL); Delivers 150 mcg/spray
- Routes of Administration: IV, IM, SC, intranasal, oral
- Common Trade Names: DDAVP, Stimate
Adult Dosing
Pediatric Dosing
Special Populations
Renal Dosing
- Adult:
- Pediatric:
Hepatic Dosing
- Adult:
- Pediatric:
Contraindications
- Allergy to class/drug
Adverse Reactions
Serious
Common
Pharmacology
- Half-life:
- Metabolism:
- Excretion: